Multiple Endocrine Neoplasia Type 1
暂无分享,去创建一个
[1] G. Valk,et al. ‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1 , 2018, Endocrine connections.
[2] G. Valk,et al. The future: medical advances in MEN1 therapeutic approaches and management strategies. , 2017, Endocrine-related cancer.
[3] O. Dekkers,et al. MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients , 2016, BMC Medicine.
[4] R. Thakker,et al. Challenges and controversies in management of pancreatic neuroendocrine tumours in patients with MEN1. , 2015, The lancet. Diabetes & endocrinology.
[5] R. Jensen,et al. Causes of Death and Prognostic Factors in Multiple Endocrine Neoplasia Type 1: A Prospective Study , 2013, Medicine.
[6] J. Bilezikian,et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). , 2012, The Journal of clinical endocrinology and metabolism.
[7] K. Dreijerink,et al. Diagnosis and Management of Multiple Endocrine Neoplasia Type 1 (MEN1). , 2005, Hereditary cancer in clinical practice.
[8] A. Gozzini,et al. Multiple endocrine neoplasia type 1 , 2006, Reviews in endocrine & metabolic disorders.